Projects per year
Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 7 Similar Profiles
Dogs
Medicine & Life Sciences
dogs
Agriculture & Biology
Canidae
Medicine & Life Sciences
drug therapy
Agriculture & Biology
lymphoma
Agriculture & Biology
Lymphoma
Medicine & Life Sciences
B-Cell Lymphoma
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2009 2020
A Novel Approach for Prevention of Canine Hemangiosarcom
Modiano, J., Borgatti, A. M., Dickerson, E. B., Henson, M. S. & Vallera, D. A.
3/1/16 → 8/31/19
Project: Research project
Hemangiosarcoma
Canidae
Preclinical evaluation and clinical translation of novel
Borgatti, A. M., Luo, X., Modiano, J., Vallera, D. A. & Yee, D.
6/1/14 → 5/31/20
Project: Research project
Sarcoma
Neoplasms
Splenic Diseases
Dog Diseases
Hemangiosarcoma
Disease Progression
Pharmaceutical Preparations
Preclinical Evaluation and Clinical Translation of Novel
Borgatti, A. M., Koopmeiners, J. & Vallera, D. A.
4/15/15 → 4/14/17
Project: Research project
Immunotoxins
Sarcoma
Lymphoma
Dogs
Therapeutics
Research Output 2005 2019
Use of computed tomography and radiation therapy planning software to develop a novel formula for body surface area calculation in dogs
Girens, R., Bukoski, A., Maitz, C. A., Boston, S. E., Borgatti, A. M., Sprinkle, M., Orrego, D., Kesl, S. & Selting, K., Mar 1 2019, In : Journal of veterinary internal medicine. 33, 2, p. 792-799 8 p.Research output: Contribution to journal › Article
Open Access
Body Surface Area
radiotherapy
computed tomography
surface area
Radiotherapy
2
Citations
(Scopus)
Phase II study of the oral selective inhibitor of nuclear export (SINE) KPT-335 (verdinexor) in dogs with lymphoma
Sadowski, A. R., Gardner, H. L., Borgatti, A. M., Wilson, H., Vail, D. M., Lachowicz, J., Manley, C., Turner, A., Klein, M. K., Waite, A., Sahora, A. & London, C. A., Aug 24 2018, In : BMC Veterinary Research. 14, 1, 250.Research output: Contribution to journal › Article
Cell Nucleus Active Transport
lymphoma
mouth
Lymphoma
Dogs
Targeting EGFR and uPAR on human rhabdomyosarcoma, osteosarcoma, and ovarian adenocarcinoma with a bispecific ligand-directed toxin
Oh, F., Todhunter, D., Taras, E., Vallera, D. A. & Borgatti, A. M., Jan 1 2018, In : Clinical Pharmacology: Advances and Applications. 10, p. 113-121 9 p.Research output: Contribution to journal › Article
Open Access
Rhabdomyosarcoma
Osteosarcoma
Epidermal Growth Factor Receptor
Adenocarcinoma
Ligands
3
Citations
(Scopus)
Targeting pediatric sarcoma with a bispecific ligand immunotoxin targeting urokinase and epidermal growth factor receptors
Pilbeam, K., Wang, H., Taras, E., Bergerson, R. J., Ettestad, B., De For, T. E., Borgatti, A. M., Vallera, D. A. & Verneris, M. R., Jan 1 2018, In : Oncotarget. 9, 15, p. 11938-11947 10 p.Research output: Contribution to journal › Article
Immunotoxins
Urokinase-Type Plasminogen Activator
Sarcoma
Plasminogen Activators
Pediatrics
1
Citation
(Scopus)
A double blinded, placebo-controlled pilot study to examine reduction of CD34+/CD117+/CD133+ lymphoma progenitor cells and duration of remission induced by neoadjuvant valspodar in dogs with large B-cell lymphoma
Modiano, J., Ito, D., Childress, M., Mason, N., Winter, A., O'Brien, T. D., Henson, M. S., Borgatti, A. M., Lewellen, M., Krick, E., Stewart, J., Lahrman, S., Rajwa, B., Scott, M. C., Seelig, D., Koopmeiners, J. & Ruetz, S., Jan 1 2017, In : F1000Research. 4, 42.Research output: Contribution to journal › Article
Lymphoid Progenitor Cells
B-Cell Lymphoma
Lymphoma
Stem Cells
Placebos